1 SCREENING AND TREATING CHILDREN WITH RISK FACTORS THAT PROMOTE CORONARY HEART DISEASE By JOLIE E. EWART A research manuscript submitted in partial fulfillment of the requirements for the degree of MASTER OF NURSING WASHINGTON STATE UNIVERSITY College of Nursing May 1998
2 11 To the Faculty ofwashington State University: The members ofthe Committee appointed to examine the clinical project ofjolie E. Ewart find it satisfactory and recommend that it be accepted.
3 iii ACKNOWLEDGEMENTS I would like to thank the following people for their support and encouragement during my graduate program. Without their help, I do not know how I would have done it. First, Jackie Banasik, my chair, for all of her teaching throughout my nursing education and for helping me to strive for excellence. Mary Kay Tucker, my office mate and friend who has been wonderful to work with and will greatly be missed. Lorna Schumann has been an inspiration with her wealth of knowledge and hard working attitude. Thank you for all of your hard work developing this program. Ruth Bindler for helping me reach my research goals and inspiring my manuscript topic. Kathy Morton, Linda Torretta, Kim Tinker, Jolene Haskins and Julie Simeoni have been there through thick and thin, helping me to complete this program. You have all been supportive and wonderful friends. Lastly, lowe great thanks to my husband Ed, for all of his support and encouragement throughout my entire nursing education.
4 iv Chair: Jacquelyne Banasik SCREENING AND TREATING CHILDREN AT RISK FOR CORONARY HEART DISEASE Abstract by Jolie E. Ewart. M.N. Washington State University May 1998 The process of atherosclerosis can begin in children and therefore. childhood should be the time to start primary prevention. Selectively screening children for hypercholesterolemia. based on family history and other risk factors. is currently recommended. Studies were analyzed to investigate the current screening recommendations and treatment options for children at risk. A brief review of coronary heart disease (CHD) and risk factors is presented. Family history is not always a reliable tool for screening children for CHD. Diet restrictions are the first line of treatment for high cholesterol. Physical activity and lifestyle change are helpful in reducing blood cholesterol. Medication should be used in high risk children when other interventions fail.
5 v TABLE OF CONTENTS Page ACKNOWLEDGEMENTS ABSTRACT LIST OF TABLES LIST OF FIGURES INTRODUCTION REVIEW OF CORONARY HEART DISEASE RISK FACTORS GUIDELINES FOR SCREENING TREATMENT CONCLUSION AND IMPLICATIONS REFERENCES iii iv vi vii
6 iv Chair: Jacquelyn Banasik SCREENING AND TREATING CHILDREN AT RISK FOR CORONARY HEART DISEASE Abstract by Jolie E. Ewart, M.N. Washington State University May 1998 The process of atherosclerosis can begin in children and therefore, childhood should be the time to start primary prevention. Selectively screening children for hypercholesterolemia, based on family history and other risk factors, is currently recommended. Studies were analyzed to investigate the current screening recommendations and treatment options for children at risk. A brief review of coronary heart disease (CHD) and risk factors is presented. Family history is not always a reliable tool for screening children for CHD. Diet restrictions are the first line of treatment for high cholesterol. Physical activity and lifestyle change are helpful in reducing blood cholesterol. Medication should be used in high risk children when other interventions fail.
7 vi LIST OF TABLES 1. Risk Factors for Coronary Heart Disease Lipid Levels for Children and Adolescents Elevated Values of Blood Pressure (>95 th percentile) Step One Diet 20
8 vii LIST OF FIGURES 1. Risk Assessment for Blood Cholesterol Screening in Children and Adolescents Classification, Education and Follow-up Based on LDL Cholesterol 22
9 1 Cardiovascular disease is the number one cause ofdeath in America. Autopsies of men and women ages who have died by accident, homicide or suicide have revealed the early formation ofcoronary artery plaques (McGill, 1997). Fatty streaks are thought to be precursors to the development ofatherosclerosis. The Bogalusa study found that extensive aortic fatty streaks were present in young children and furthermore, in male subjects, the amount offatty deposition correlated with the child's serum lipids, triglycerides, and blood pressure (Berenson et ai., 1992). Since the process of atherosclerosis can begin in childhood, it is recommended that practitioners begin screening and primary prevention early to decrease the early onset ofcoronary heart disease (CHD). The purpose ofthis manuscript is to discuss the pathophysiology of plaque formation including the proposed role ofcholesterol, hypertension, and other risk factors in children and adolescents. Guidelines for screening and treating children for atherosclerotic risk factors will be suggested based on current research. Review ofcoronary Heart Disease The primary role ofthe coronary arteries is to provide for the metabolic needs ofthe heart by delivering oxygen and fuel for myocardial work. Coronary atherosclerosis or CHD, causes a disruption in the delivery system by reducing the lumen of the blood vessels. The process ofplaque formation usually takes many years to occur. Hypertension, infection, or trauma can cause the initial endothelial injury to the coronary vessels (Baxendale, 1992). When this injury occurs, the body responds by triggering repair processes. These repair processes can cause the vasculature to thicken at the inner aspect ofthe arterial wall(s). According to Baxendale (1992), "ifthe injury is transient,
10 2 the lesion will regress and not evolve into a plaque. Chronic injury, however, promotes the formation ofa plaque via reinforcement ofthe repair cascade" (p. 145). The repair cascade begins when monocytes and platelets aggregate at the site ofinjury and release growth factors which stimulate DNA synthesis and proliferation of smooth muscle cells and fibrous tissue (Baxendale, 1992). The release ofother toxic substances known as free radicals, along with the release ofgrowth factors, contributes to the development ofplaques and the deposition oflipids (Baxendale, 1992). Low density lipoproteins (LDL-Cs) and very low density lipoproteins (VLDL-Cs) are the major cholesterol carrying lipoproteins in plasma (Rotter et ai., 1996). They are associated with increased plaque formation when elevated. As the inner walls ofthe arteries become congested with plaques, the blood can not pass through smoothly. With greater than 75% occlusion, the person nlay begin to experience synlptoms ofatherosclerosis, such as angina. A rough or fractured plaque may stimulate thrombus formation, resulting in complete occlusion and myocardial infarction. High density lipoproteins (HDL-Cs) on the other hand, are thought to be protective against CHD. HDL-C primarily functions to transport cholesterol from the extrahepatic organs and the arterial walls to the liver for excretion (Dietschy, 1997). Risk Factors Many risk factors (see Table 1) thought to increase the likelihood of developing CHD have been identified. Although family history ofchd is an important indicator of risk, studies have found that increased total cholesterol and LDL-C, along with low levels of HDL-C, maybe better indicators ofincreased risk for CHD (Filer, Lauer & Luepker,
11 3 1994). High blood pressure, obesity, smoking, high fat and high cholesterol diet, and inactivity are all modifiable risk factors associated with increased risk for CHD. Hypercholesterolemia The Bogalusa Heart Study, a longitudinal, descriptive study of biracial children from birth through the age of 31 that began in 1973, found significant relationships between total cholesterol and LDL cholesterol level and the extent ofaortic fatty streaks in children (Filer, Lauer & Luepker, 1994). Diets that are high in cholesterol and saturated fatty acids are thought to be the major contributors to increased blood cholesterol in children (Filer et ai., 1994). Some children have increased cholesterol that is resistant to diet and activity changes, as the result ofa dominant genetic predisposition. Children with familial hypercholesterolemia, for example, have LDL cholesterol levels that are elevated two to three-fold, and in rare cases, five to six-fold (Kwiterovich, 1995). This is a rare condition and not the topic ofthis paper. An expert panel has recommended that target total cholesterol should be below 170 mg/dl and LDL-C should be below 110 mg/dl in children. The acceptable, borderline and high lipid values for children and adolescents are shown in Table 2 (National Cholesterol Education Progranl (NCEP), 1991). High Blood Pressure Hypertension increases stress on the arterial walls, compromising permeability and increasing the deposition oflipids (Baxendale, 1992). High blood pressure in children is defined as systolic blood pressure consistently above the 95 th percentile. High blood pressure can be caused by renal, vascular, endocrine, or neurologic disorders, certain
12 4 medications, or evolve from other etiologies (Kwiterovich, 1995, p. 317). In children older than ten years, the cause is often unknown and referred to as primary or essential hypertension. High blood pressure frequently occurs in offspring ofparents with high blood pressure (Purath, 1995). Age related values for high blood pressure are outlined in Table 3. Obesity Obesity is a growing problem among children and adolescents. Since the 1960s, the proportion of six through eleven year olds with obesity has increased 48% and the proportion oftwelve through seventeen-year olds with obesity has increased 42% (Troiano, Flegal, Kuczmarski, Campbell & Johnson, 1995). There are correlations for obesity with elevated cholesterol and elevated blood pressure. This makes obesity a strong contributing factor for CHD (Taubert, Moller & Washington, 1996). Obesity is often associated with inactivity and a high fat diet which are additional CHD risk factors. According to Nicklas (1995), the average energy intake of ten-year old children between the years 1973 and 1988 has remained the same. Individuals in the latter years ofthis 20 year study however, were on average, three pounds heavier. More than 75% ofchildren consume more total fat, saturated fat and cholesterol than the recommended amount. The reported change in weight may be due to a decrease in activity and an increase in the number ofyouths with a sedentary lifestyle. Kohn and Jacobson (1996) state that 36% of total calories come from fat in the typical diet ofchildren in the United States. The recommendation by the Expert Panel on Blood Cholesterol Levels from the NCEP (1991) is that total fat be less than 30% oftotal calories.
13 5 Hayman, Meininger, Coates, and Fallagher (1995) studied twins during the schoolaged years and at adolescence to examine non-genetic influences on obesity, lipid profile and blood pressure. Obesity was assessed by measuring body mass index (BMI) and skinfold thickness. Children with a skinfold thickness 2: 75 th percentile were considered obese. The change in obesity measurements over time between the twins was calculated. The authors found that from the school age years to adolescence, environmental influences were substantial with a mean intrapair weight difference of 1.11 kg. The results suggested that influences other than genetics, had an effect on obesity and contributed to the variability in HDL cholesterol and the triglyceride levels. Unfortunately, the authors did not identify the other influences or control for them. However, the authors suggested that overweight or obese children should be monitored closely for elevated cholesterol and elevated blood pressure throughout childhood and adolescence. Smoking Tobacco is a major risk factor for CHD and stroke along with lung disease and cancer. Despite the known risk involved with smoking, substantial numbers ofchildren and adolescents continue to begin smoking at early ages. Between 80 to 90% of smokers begin before the age of21 (Torabi & Nakornkhet, 1996). Torabi and Nakornkhet (1996) also state that "tobacco is the single most preventable cause of death in the United States and is responsible for one in five deaths" (p. S-40). Tobacco reportedly is the only legal substance that ifused as intended will cause addiction, disease and early death (Taubert, Moller & Washington, 1996). Although the total cholesterol ofyouths that snloke has been found to be lower than non-smokers, the beneficial HDL cholesterol is also lower
14 6 and thus creates the lower total cholesterol value (Bermingham, Jones, Steinbeck & Brock, 1995). Guidelines for Screening According to the Expert Panel on Blood Cholesterol Levels in Children and Adolescents ofthe NCEP (1991) selective screening rather than universal screening for elevated cholesterol levels should be done. The panel recommends that children with a family history ofchd have a complete lipid profile evaluated. However, the panel does not state at what age to begin screening. A significant family history includes parents and grandparents that have had either an arteriogram that indicated atherosclerosis or who suffered a documented myocardial infarction, angina pectoris, peripheral vascular disease, cerebrovascular disease or sudden cardiac death before age 55 (p. 5). The panel also recommends that children ofa parent with high blood cholesterol (>240 mg/dl) have their total cholesterols measured. Primary care providers may choose to screen individuals with other risk factors including high fat diet, high blood pressure, obesity and/or smoking. Screening should be repeated based on the initial results within one to five years (p. 8). An example ofan appropriate screening protocol for children with increased cholesterol is included in Figure 1 (NCEP, 1991). This protocol determines the necessity ofgeneral cholesterol screening versus the more extensive lipoprotein analysis. Figure 2 (NCEP, 1991), provides further guidelines for follow-up based on the LDL cholesterol. Ali, Bandh and Hasson (1995) found that children ofparents with CHD had significantly higher levels ofcholesterol, triglycerides and LDL cholesterol by 31.8%, 6.8% and 36% respectively, compared to children with no family history ofchd.
15 7 Children with a family history ofchd should be screened for both lipoproteins and triglycerides. "Children ofparents with combination of CHD and hyperlipidemia are at increased risk ofdeveloping early atherosclerosis and need lipid estimation screening" (p. 289). Gagliano, Enlans and Woods (1993) suggest that adolescents over age 11 be screened rather than children, to avoid testing during the years ofsignificant cholesterol level fluctuations and to do so when a change in diet would have less impact on the growing child. There are multiple reasons for the controversy regarding who should be screened and when. The advantages and disadvantages ofuniversal screening are discussed below. Advantages ofuniversal Screening Gagliano et al. (1993) concluded from their study that individualized screening is not adequate and that family history is not always predictive ofhypercholesterolemia. Forty eight percent ofadolescents with increased cholesterol would have been missed if screening was based on a family history ofchd or cholesterol levels over 240 mg/dl. Gagliano et al. (1993) also found that many parents were unaware oftheir own or their parents' cholesterol levels. Most ofthe parents were in their early 40s and had not yet experienced any symptoms of CHD. This is not to say that they did not have hypercholesterolemia, but that they had not yet been diagnosed. Often, there was a significant difference in adolescents' report ofpositive family history ofeither elevated lipids or early myocardial infarction, when compared with the history given by the parent, with only a 17% positive-predictive value. A positive family history given by either the parent or adolescent had a 19% positive-predicative value.
16 8 Purath, Lansinger and Ragheb (1995) screened for family diseases, and cholesterol levels in school aged children (N = 357). There was no significant relationship between family history and elevated cholesterol. "Ifthe recommended guidelines ofscreening only those children with a positive family history of CHD had been followed, 66.2% of children with cholesterol levels greater than 170 mg/dl would not have been identified" (p. 193). The advantage of universal screening is that the likelihood of missing a child with elevated cholesterol is decreased. When children are identified for risk early, primary prevention can be instituted. Risk factors can potentially be lowered, ifchildren learn healthy habits at a young age. By reducing fat in their diet, avoiding obesity, inactivity and smoking, habits are established that may decrease the risk for developing CHD in adulthood. Ideally, these health habits should be taught to all children regardless of cholesterol level. Disadvantages ofuniversal Screening Some disadvantages ofuniversal screening include the fear that some children may inappropriately be labeled as having a disease that does not later develop. The potential for overuse ofcholesterol lowering drugs in childhood and adolescence is another concern, especially with children who are having transitional fluctuations. Furthermore, the expense of screening everyone, cannot be overlooked in this era ofhealth care cost reduction. The cost of screening for total cholesterol is approximately $ The complete lipid panel which includes total cholesterol, triglycerides, high and low density lipids and their ratio is on average $30.00.
17 9 Treatment Generally children and adolescents with hypercholesterolemia are treated initially with a modified diet. NCEP (1991) recomnlends the Step One diet for borderline and high levels ofldl cholesterol. The Step One diet is listed in Table 4. Goals oftreatment, as stated previously, are to lower total cholesterol and LDL cholesterol below 170 mg/dl and 110 mg/dl. Behavioral risk factor reduction should be implemented, including increased exercise, diet modification ifnecessary, attempts to prevent or quit smoking and identification and treatment of high blood pressure. Exercise and Diet Education Kahle et al. suggest that "a modest change in chronic physical exertion, planned as a routine exercise program for obese adolescent males, is associated with improvements in glucose homeostasis and decreases in peripheral insulin levels" (Kahle, Zipf, Lamb, Horswill & Ward,1996, p. 5). In their study of seven obese males, the authors observed a consistent reduction in LDL cholesterol (25%), total cholesterol to HDL cholesterol ratio, and resting systolic blood pressure throughout the 15 week study. However, this trend was not statistically significant. The authors suggest that ifthe study continued, the positive effects on cholesterol and blood pressure may have continued (Kahle, et ai., 1996). The effects ofphysical training versus lifestyle education on childhood risk factors for CHD were studied over a 10-week period by Gutin, Cucuzzo, Islam, Smith and Stachura (1996). Percent body fat, aerobic fitness, lipid profile, glucose and insulin values and diet intake were all measured pre- and post-intervention in 22 obese, black females, ages Aerobic fitness was measured on a treadmill with an electrocardiograph measuring heart
18 10 rate. Body composition was assessed by measuring percent body fat with dual x-ray absorptiometry. Both groups reduced total cholesterollhdl cholesterol ratio and triglycerides. The physical training group improved in aerobic fitness and body composition. The lifestyle education group improved their diets. The authors suggested that "a conlbination ofphysical training and lifestyle education may be more effective than either alone" (p.22). However, the small sample size and lack of control group should be noted in this study. Adherence to a restricted diet is very difficult for young people to accomplish. Children ages 7-17 with familial hypercholesterolemia were studied to determine factors successful in maintaining a healthy diet (Tonstad & Sivertsen, 1997). Psychosocial function ofthe child and parental education level were factors associated with increased adherence to a healthy diet. Psychosocial function and behavioral problems were measured using questionnaires, filled out by both the parents and the child. Other factors such as parental CHD, baseline serum cholesterol, age, sex, and BMI did not predict adherence to diet. Children that did well, may have done so because oftheir ability to function well overall and perhaps because of family support. Howard, Bindler, Synoground and Van Genlert (1996) studied the effectiveness of teaching about physiology ofthe heart and cardiovascular risk factors on knowledge and cholesterol levels in 51 fourth through sixth graders, compared with 47 fourth through sixth graders who received no intervention. After one year, the five 40-minute educational programs did not result in higher test scores on the physiology ofthe heart and cardiovascular risk factors compared to the control group. Total cholesterol and LDL cholesterol levels in both groups were lower than baseline at one year. The total
19 11 cholesterol was between the 75 th and 95 th percentile initially for most participants in both groups and dropped to the 5 th to 25 th percentile for most participants in the control group and to the 25 th to 50 th percentile for those in the experimental group at one year. The authors suggest that perhaps the cholesterol levels ofchildren in this age group fluctuate regardless of intervention or that being in a study motivates all children to make changes that lower cholesterol levels. Medication Treating children with cholesterol lowering medications should be considered only after unsuccessful reductions in cholesterol with diet and exercise modification. Medication should be considered when a parent has died or had severe atherosclerotic sequelae in their 40s or younger, or the adolescent's LDL cholesterol is greater than 190 mg/dl in the absence ofother risk factors or greater than 160 mg/dl with concurrent smoking, hypertension, xanthomas, diabetes or clinical signs ofatherosclerosis (Kohn & Jacobson, 1996, p. 820). NCEP (1991) recommends drug therapy in children 10 years and older who do not adequately respond to diet changes over six months to one year and have LDL cholesterol levels 2: 190 mg/dl or LDL 2: 160 mg/dl and have a positive family history ofpremature CHD (before age 55) or have two or more other CHD risk factors. Bile acid sequestrants, cholestyramine and colestipol, are currently being used with children due to their relatively low side effects and apparent safety. Bile acid sequestrants work by binding bile acids in the intestinal lumen. Nicotinic acid has not been proven to be safe in children and should be used cautiously and only after referral to a lipid specialist (NCEP, 1991).
20 12 Most ofthe statin drugs are not recommended in children. However, atorvastatin (Lipitor) has been used in a limited number of children nine years ofage and older for one year with no unusual adverse effects (American Hospital Formulary Service, 1998). Although atorvastatin has been shown to reduce cholesterol levels in adults ("What's New in Drugs", 1997), caution should be taken with prescribing this to children until further studies have been done. Smoking Prevention and Cessation For smoking cessation guidelines and packets, the National Cancer Institute at CANCER may be contacted. They offer "Clearing the air: A guide to quitting smoking" and "How to help your patients stop smoking: A National Cancer Institute manual for physicians." Smoking prevention is a challenge for parents, schools and health care providers that must continue to be addressed. Conclusion and Implications The studies reviewed indicate that family history is not always a reliable tool for determining which children should be screened for elevated cholesterol and triglycerides. Other risk factors including high fat diet, high blood pressure, obesity, inactivity, and smoking should be part ofthe assessment for CHD risk. When these factors are present, health care providers should consider assessing total cholesterol or a lipid panel, if indicated. The advantage of screening all children and adolescents is to ensure that certain children who fall into the high-risk group do not get missed. This is not the current recommendation however, and may not be realistic due to issues ofcost and also the fact that not all children have access to health care. Other disadvantages of screening all children and adolescents include, falsely diagnosing disease in children who will not
21 13 later develop CHD as adults and the potential for overuse of cholesterol lowering drugs in children. Furthermore, all children should receive guidance and education on CHD and risk reduction regardless ofwhether they have elevated cholesterol or a family history of CHD. Diet intervention is the first line oftreatment for children shown to be at risk for CHD. Lifestyle change and physical activity also have been shown to decrease cholesterol levels. Smoking prevention and cessation should be routinely addressed at health care visits. Health care providers have the opportunity to detect the early developnlent of CHD and by intervening before the disease progresses, can potentially reduce morbidity and mortality. A need for future research studies in children has been identified. Effects ofvarying amounts ofcigarettes on the risk for CHD, need further study. Also, longitudinal studies on the effects of routine exercise on cholesterol levels in youths would be beneficial. The benefits and risks involved with treating children with cholesterol reducing medications is important. Studies should also evaluate how well interventions for cholesterol reduction in children influence CHD incidence in adulthood. Identification of interventions helpful to motivate children to actively try to lower their cholesterol levels is also needed.
22 14 References Ali, W., Bandh, A., & Hassan, M.V. (1995). Serum lipid profile in children of coronary heart disease patients. Indian Journal ofphysiological Pharmacology, 39, American Hospital Formulary Service. (1998). Drug information. Bethesda, MD: American Society of Health System Pharmacists. Baxendale, L.M. (1992). Pathophysiology ofcoronary artery disease. Nursing Clinics ofnorth America, 27, Berenson, G.S., Wattigney, W.A., Tracy, R.E., Newman, W.P., Srinivasan, S.R., Webber, L.S., Dalferes, E.R., & Strong, J.P. (1992). Atherosclerosis ofthe aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). American Journal ofcardiology, 70, Bermingham, M.A., Jones, E., Steinbeck, K., & Brock, K. (1995). Plasma cholesterol and other cardiac risk factors in adolescent girls. Archives ofdisease in Childhood, 73, Dietschy, J.M. (1997). Theoretical considerations ofwhat regulates low-densitylipoprotein and high-density-lipoprotein cholesterol. American Journal ofclinical Nutrition, 65, 1581S-9S. Filer, L. J., Lauer, R.M., & Luepker, R.V. (Eds.). (1994). Prevention ofatherosclerosis and hypertension beginning in youth. Malvern, PA: Lea & Febiger. Gagliano, N.J., Emans, J., & Woods, E.R. (1993). Cholesterol screening in the adolescent. Journal ofadolescent Health, 14,
23 15 Gutin, B., Cucuzzo, N., Islam, S., Smith, C. & Stachura, M.E. (1996). Physical training, lifestyle education, and coronary risk factors in obese girls. Medicine and Science in Sports and Exercise, 28(1), Hayman, L.L., Meininger, J.C., Coates, P.M., & Gallagher, P.R. (1995). Nongenetic influences ofobesity on risk factors for cardiovascular disease during two phases of development. Nursing Research, 44, Howard, J.K.H., Bindler, R.M., Synoground, G., & Van Gernert, F.C. (1996). A cardiovascular risk reduction program for the classroom. Journal of School Nursing, 12(4), Kahle, E.B., Zipf, W.B., Lamb, D.R., Horswill, C.A., & Ward, K.M. (1996). Association between mild, routine exercise and improved insulin dynamics and glucose control in obese adolescents. International Journal of Sports Medicine, 17(1), 1-6. Kohn, M.R., & Jacobson, M.S. (1996). Cholesterol in adolescents: Whom to screen & how to treat. Comprehensive Therapy, 22, Kwiterovich, P.O. (1995). Detection and treatment ofelevated blood lipids and other risk factors for coronary artery diseases in youth. Annals ofthe New York AcadenlY of Sciences, 748, McGill, H. (1997). Risks for atherosclerosis affect adolescents, adults. Disease State Management, 5, National Cholesterol Education Program (1991). Report ofthe expert panel on blood cholesterol levels in children and adolescents. Bethesda, MD: National Institutes of Health.
24 16 Nicklas, T.A. (1995). Dietary studies ofchildren: The Bogalusa Heart Study experience. Journal ofthe American Dietetic Association, 95, Purath, J. (1995). Pediatric hypertension: Assessment and management. Pediatric Nursing, 21, Purath, J., Lansinger, T., & Ragheb, C. (1995). Cardiac risk evaluation for elementary school children. Public Health Nursing, 12, Rotter, J.I., Bu, X., Cantor, R.M., Warden, C.H., Brown, J., Gray, R.J., Blanche, P.J., Krauss, R.M., & Lusis, A.J. (1996). Multilocus genetic determinants ofldl particle size in coronary artery disease families. American Journal of Human Genetics, 58, Taubert, K.A. Moller, J.H., & Washington R. L. (1996 supp.). The current status of children's cardiovascular health. Journal ofhealth Education, 27(5), Tonstad, S.& Sivertsen, M. (1997). Dietary adherence in children with familial hypercholesterolemia. American Journal of Clinical Nutrition, 65, Torabi, M.R., & Nakornkhet, N. (1996 supp.). Smoking among teenagers: Educational recommendations and resources. Journal ofhealth Education, 27(5), Troiano, R.P., Flegal, K.M., Kuczmarski, R.J. Campbell, S.M., &Johnson, C.L. (1995). Overweight prevalence and trends for children and adolescents. Archives of Pediatric Adolescent Medicine, 149, What's new in drugs: A more aggressive statin reaches the market. (1997). RN, 60(4),
Dyslipidemia and obesity History: A 13-year-old girl is seen for a routine clinic follow-up visit. She has been previously healthy, but her growth curve shows increasing body mass index (BMI) percentiles
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
High Cholesterol (Hyperlipidemia) My cholesterol medication is: The directions are: In recent years, powerful new drugs have been developed to reduce cholesterol in your blood, thereby reducing your risk
High Cholesterol Frequently Asked Questions (FAQ) What is Cholesterol? LDL and HDL Cholesterol: What's Bad and What's Good? What Can Cholesterol Do? What is Atherosclerosis? How does atherosclerosis start?
University of Michigan Hospitals and Health Centers Pediatric Metabolic Syndrome A growing epidemic Shannon Russell Dietetic Intern June 2012 Overview Causes Risk Factors Signs and Symptoms Identification/Diagnosis
South African Cholesterol Guidelines Compared Jacqueline van Schoor, Amayeza Info Centre While infectious diseases are currently the leading cause of death in South Africa, cardiovascular disease (CVD)
Primary Care Management of Women with Hyperlipidemia Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing Objectives: Define dyslipidemia in women Discuss the investigation process leading
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
Prevention of Cardiovascular Disease in Children with Diabetes Stephen R. Daniels, MD, PhD Department of Pediatrics University of Colorado School of Medicine The Children s Hospital Anschutz Medical Campus
Dyslipidemia and type 2 diabetes mellitus History: A 17-year-old Hispanic female patient is seen for a routine clinic follow-up visit. She was diagnosed with type 2 diabetes 6 months ago. Her hemoglobin
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates
Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 In 2002, SETMA began a relationship with Joslin Diabetes
is designed for the workplace looking for a single, comprehensive set of tests that establish baseline laboratory values for wellness and disease management programs. The Test Package describes the normal
Understanding and Managing Your Triglycerides What are Triglycerides? There are several types are one of several types of fat in your body, and triglycerides are the most common. Along with LDL ( bad )
Do You Know The Important Risk Factor and Fitness Assessment Numbers? Jonathan N. Mike M.S. and Len Kravitz, Ph.D. Introduction One of the principal areas of concern for exercise professionals is assessing,
Nutrition: Knowing Your Total Cholesterol A number of factors can increase your risk for coronary heart disease. To make an accurate assessment your doctor will determine your lipid profile, overall health,
Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced
Obesity What is obesity? Overweight and obesity together represent the second leading preventable cause of death in the United States. Obesity is a serious, chronic disease that can inflict substantial
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
What You Need to Know about High Blood Why is high cholesterol bad? is a natural substance found in our diet and made by our liver. It is important for many functions throughout our body. High blood cholesterol
1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:
WBC 4.00-10.50 WBC measures the total number of white blood cells in a given volume of blood. Since white blood cells kill bacteria, this count is a measure of the body s response to infection. In general,
Position Statement Statins, healthy diet and cholesterol January 2014 Recent media coverage claiming that high cholesterol does not cause heart disease, and also questioning the benefits of using statins
Complete Summary GUIDELINE TITLE (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
MEETING YOUR GOALS An Overview and Guide to Healthy Living with Type 2 Diabetes MEETING YOUR GOALS This brochure was designed to help you understand the health goals to live a healthy lifestyle with type
Effect of Exercise on BMI and Biochemical Profile of Selected Obese Diabetic Women Nazni, P. *, Poongodi Vijayakumar, T. ** & Angamuthu, K. *** * Lecturer, Department of Food Science, Periyar University,
Diabetes and Stroke Understanding the connection between diabetes and the increased risk of stroke Make the Connection Almost 26 million people in the U.S. roughly 8 percent of the population have diabetes.
Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the
National Cholesterol Education Program High Blood Cholesterol What you need to know Why Is Cholesterol Important? Your blood cholesterol level has a lot to do with your chances of getting heart disease.
Web Quest Abstract Students explore the Using Family History to Improve Your Health module on the Genetic Science Learning Center website to complete a web quest. Learning Objectives Chronic diseases such
Cholesterol and Triglycerides What You Should Know Michael T. McDermott MD Professor of Medicine Endocrinology Practice Director Division of Endocrinology, Metabolism and Diabetes University of Colorado
Cardiac Rehabilitation Introduction Experiencing heart disease should be the beginning of a new, healthier lifestyle. Cardiac rehabilitation helps you in two ways. First, it helps your heart recover through
YOUR GUIDE TO Managing and Understanding Your Cholesterol Levels Our goal at the Mercy Health Heart Institute is to help you be well. Our experienced team includes cardiologists, cardiovascular surgeons,
Sinclair Community College, Division of Allied Health Technologies Health Promotion for Community Health Workers Cardiovascular disease, stroke, and cancer Class #5 High Blood Cholesterol (date) Course
Cholesterol a biomolecule Bad cholesterol a strange tale Good cholesterol - indeed Thomas B. Kuhn: University of Alaska, Cereon Biotechnology LLC This document is protected by copyright Dr. Thomas B. Kuhn
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING
Triglycerides & HDL-C Thomas Dayspring, MD, ACP Clinical Assistant Professor of Medicine University of Medicine and Dentistry of New Jersey Attending in Medicine: St Joseph s s Hospital, Paterson, NJ Certified
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
How to Prevent Heart Disease Introduction Heart disease is the leading cause of death worldwide. You can reduce your risk of heart disease with healthy habits. This reference summary explains heart disease
Thresholds for Use With ACSM Risk Stratification (p 24G) ACSM Risk Factor Identification and Risk Stratification By Dr. Sue Beckham, Ph.D., RCEP, PD Positive Family History Cigarette Smoking Myocardial
Cholesterol a biomolecule Bad cholesterol a strange tale Good cholesterol - indeed Thomas B. Kuhn: University of Alaska, Cereon Biotechnology LLC This document is protected by copyright Dr. Thomas B. Kuhn
Component of Statistics Canada Catalogue no. 82-625-X Health Fact Sheets Article Heart health and cholesterol levels of Canadians, 2007 to 2009 March How to obtain more information For information about
S What is Heart Failure? 1,2,3 Heart failure, sometimes called congestive heart failure, develops over many years and results when the heart muscle struggles to supply the required oxygen-rich blood to
Health Passport Your Journey to Wellness Health Fair ID# Body Mass Index What is BMI? Your body mass index, or BMI, shows the amount of fat in your body. BMI is calculated using height, weight, and waist
BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,
Cholesterol Congestion How your blood cholesterol traffic is measured The odds of getting cardiovascular disease are very high; it is the main cause of death in the US and more than one in four Americans
Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).
New Cholesterol Treatment Guidelines Charles F. Dahl, MD, FACC Cardiologist and Lipidologist, Central Utah Clinic Objectives: List the 4 treatment groups under the new guidelines Identify how to calculate
DIABETIC AWARENESS CAMP We have organized Diabetic awareness camp on world Diabetic Day on dt.14/11/11 at village Samser padar with the following objectives: 1. Awareness raising on diabetic 2. Frequently
YOUR GUIDE TO Lowering The Risk of Heart Attack and Stroke The Mercy Health Heart Institute team is focused on helping you keep your heart healthy. As part of this effort, it s important for you to know
The American college of cardiology (ACC) and American Heart Association (AHA) in combination with National Heart, Lung and blood institute (NHLBI) have released 4 new guidelines. At the invitation of the
Omega-3 fatty acids on heart function (including anti-arrhythmic effects), hemo-dynamics (cardiac mechanics) and arterial endothelial function. The link between omega-3 fatty acids and CVD risk reduction
Texto proveniente de: ACSM s Certified News Peripheral Arterial Disease By Nina Markil, B.S. Exercise Science and Health Promotion at Florida Atlantic University. CNews19.2Final.JR:Layout 1 5/6/09 Peripheral
ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE I- BACKGROUND: Coronary artery disease and stoke are the major killers in the United States.
S What is a Heart Attack? 1,2,3 Heart attacks, otherwise known as myocardial infarctions, are caused when the blood supply to a section of the heart is suddenly disrupted. Without the oxygen supplied by
Facts About Peripheral Arterial Disease (P.A.D.) One in every 20 Americans over the age of 50 has P.A.D., a condition that raises the risk for heart attack and stroke. Peripheral arterial disease, or P.A.D.,
Clinical guidelines usually recommend that the level of high density lipoprotein cholesterol (HDL-C) should be measured. It is frequently argued that HDL-C levels below 35 mg/dl are causally associated
International Task Force for Prevention Of Coronary Heart Disease Coronary heart disease and stroke: Risk factors and global risk Slide Kit 1 (Prospective Cardiovascular Münster Heart Study) Design and
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
The Circulatory System Components The human circulatory system is made up of 3 main parts: The heart Blood vessels (arteries, veins, capillaries) Blood The Human Heart The human heart is made of 3 types
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
Patient decision aid Taking a statin to reduce the risk of coronary heart disease and stroke http://www.nice.org.uk/guidance/cg181/resources/cg181-lipid-modification-update-patient-decisionaid2 Published:
ASCVD Risk Calculators, Controversies and Women Ann Cannon, RN, BSN Clinical Specialist for Cardiovascular Health and Heart Failure, MaineHealth Nurse Care Manager, Turning Point Heart Health Program Maine
my Complete Cholesterol Profile and Action Plan Your healthcare provider, along with this brochure, can help you better understand your Complete Cholesterol Profile, which may help you improve your cholesterol
Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care
CLINICALLY T E S T E D Natural Blood Sugar Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Metabolic Syndrome with Prediabetic
Blood Pressure Weight BMI Blood Sugar KNOW YOUR holesterol LDLHDL Numbers Triglycerides Your health truly is the most important thing in your life. Knowing your medical history and getting annual checkups
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
Cholesterol Treatment Trialists (CTT) Collaboration Slide deck CTT Collaboration: Background* History: Founded in 1993 (prior to publication of 4S trial in 1994) Original protocol published in 1995 Trial
Page 1 of 6 PHA-GEN-003-2004 Cholesterol for Your Health Things that you will learn from reading through this packet include: What the fuss about cholesterol and other lipids is all about What the risk
Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults
Cardiovascular Fitness The body s ability to efficiently pump blood throughout the body. http://www.phschool.com/science/biology_place/biocoach/cardio1/intro.html Heart Disease is one of the top causes